Gaceta Médica de México

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Gaceta Médica de México >Year 2009, Issue 4

Cervantes-Arriaga A, Rodríguez-Violante M, Villar-Velarde A, Vargas-Cañas S
Cardiomiopatía hipertrófica en ataxia de Friedreich. Presentación de dos casos
Gac Med Mex 2009; 145 (4)

Language: Español
References: 16
Page: 343-346
PDF: 111.58 Kb.

Full text


Background: Friedreich’s ataxia is the most common hereditary ataxia and its clinical spectrum includes cardiac disease, mainly hypertrophic cardiomyopathy.
Methods: We present two cases with molecular diagnosis of Friedreich’s ataxia and cardiac disease shown on electrocardiogram and echocardiogram.
Results: Neurological symptoms which lead to the diagnosis are described together with cardiac comorbidities.
Conclusions: The cases here described highlight the importance of early screening and identification of systemic complications, specifically cardiac disease, in patients with this neurological disease.

Key words: Friedreich’s ataxia, cardiopathy, hypertrophic cardiomyopathy.


  1. Unverferth DV, Schmidt WR, Baker PB, Wooley CF. Morphologic and functional characteristics of the heart in Friedreich’s ataxia. Am J Med 1987;82:5-10.

  2. Harding AE, Hewer RL. The heart disease of Friedreich’s ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. Q J Med 1983;52:489-502.

  3. Spear WH, Wilber DJ. Cardiac arrhytmias. En: Biller J, editor. The interface of neurology and internal medicine. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 63.

  4. Hewer RL. Study of fatal cases of Friedreich’s ataxia. Br Med J 1968;3:649-652.

  5. Rasmussen A, Gómez M, Alonso E, Bidichandani SI. Clinical heterogeneity of recessive ataxia in the Mexican population. J Neurol Neurosurg Psychiatry 2006;77:1370-1372.

  6. Pandolfo M. Friedreich ataxia: The clinical picture. J Neurol 2009;256(Suppl 1):3-8.

  7. Pandolfo M. Friedreich ataxia. Arch Neurol 2008;65:1296-1303.

  8. Harding AE. Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981;104:589-620.

  9. Dutka DP, Donnelly JE, Palka P, Lange A, Núñez D, Nihoyannopoulos P. Echocardiographic characterization of cardiomyopathy in Friedreich’s ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation 2000;102:1276-1282.

  10. Ribaï P, Pousset F, Tanguy ML, Rivaud-Pechoux S, Le Ber I, Gasparini F, et al. Neurological, cardiological and oculomotor progression in 104 patients with Friedereich ataxia during long term follow up. Arch Neurol 2007;64:558-564.

  11. Meyer C, Schmid G, Görlitz S, Ernst M, Wilkens C, Wilhelms I, et al. Cardiomyopathy in Friedreich’s ataxia. Assessment by cardiac MRI. Mov Disord 2007; 22:1615-1622.

  12. Giuglano GR, Sethi PS. Friedreich’s ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 2007;34:214-217.

  13. Di Prospero NA, Baker A, Jeffries N, Fischbeck KH. Neurological effects of high-dose idebenone in patient’s with Friedreich’s ataxia: a randomized, placebo-controlled trial. Lancet Neurol 2007;6:878-886.

  14. Buyse G, Mertens L, Di Salvo G, Matthijs I, Weidemann F, Eyskens B, et al. Idebenone treatment in Friedreich’s ataxia: neurological, cardiac, and biochemical monitoring. Neurology 2003; 60: 1679-1681.

  15. Hausse AO, Aggoun Y, Bonnet D, et al. Idebenone and reduced cardiac hypertrophy in Friedreich’s ataxia. Heart 2002;87:346-349.

  16. Schöls L, Zange J, Abele M, Schillings M, Skipka G, Kuntz-Hehner S, et al. L-carnitine and creatine in Friedreich’s ataxia. A randomized, placebocontrolled crossover trial. J Neural Transm 2005;112:789-796.

>Journals >Gaceta Médica de México >Year 2009, Issue 4

· Journal Index 
· Links 

Copyright 2019